Markets › India › NSE › NATCOPHARM

Natco Pharma Ltd

NSE:NATCOPHARMHealthcareNSE:CNX500NSE:CNXSMALLCAP

₹800.85+2.01%At closeAt close · Mon 19 Oct · ≈ AED 30.94 · Market cap $1.62B · Next earnings Tue 17 Nov

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	74.1%	70.0%	75.8%	81.3%	83.6%	83.1%	—	—
Operating margin	45.3%	35.6%	55.1%	64.9%	67.7%	30.2%	30.2%	+0.0 pts
Net margin	21.4%	8.7%	26.4%	34.7%	42.5%	34.8%	36.6%	+1.8 pts
EBITDA margin	29.5%	13.4%	35.7%	43.7%	48.4%	42.5%	—	—
Return on equity	10.7%	4.0%	14.7%	23.7%	24.8%	15.4%	16.2%	+0.8 pts
Return on assets	9.2%	3.3%	12.6%	20.1%	21.8%	12.8%	13.5%	+0.7 pts
Return on capital employed	21.8%	15.8%	30.0%	43.8%	39.0%	13.1%	—	—
Debt / equity	0.1×	0.1×	0.0×	0.1×	0.0×	0.1×	0.1×	+0.0%
Debt / assets	5.9%	8.5%	3.1%	5.6%	3.2%	6.4%	—	—
Interest coverage	70.0×	39.2×	102.9×	135.2×	164.0×	33.5×	—	—
Current ratio	4.4×	3.5×	4.4×	4.1×	5.6×	3.0×	3.0×	+0.0%
Quick ratio	2.7×	2.3×	3.2×	3.3×	4.8×	2.5×	—	—
Cash ratio	0.0×	0.2×	0.2×	0.1×	2.3×	0.9×	0.9×	+0.0%
Asset turnover	0.4×	0.4×	0.5×	0.6×	0.5×	0.4×	—	—
Inventory turnover	0.6×	0.7×	0.8×	0.9×	0.9×	0.8×	—	—
Receivables turnover	4.1×	2.8×	3.0×	3.2×	3.5×	4.6×	—	—
Dividend payout	25.8%	48.4%	14.0%	12.3%	5.7%	6.4%	—	—

Margins, returns, leverage and liquidityUpdated Tue 31 Mar ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.